Oncology Today with Dr Neil Love

Data + Perspectives: Clinical Investigators Discuss the Role of CAR T-Cell Therapy for Patients with Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia

Oncology Q&A for Patients with Metastatic Triple-Negative Breast Cancer

CAR T-Cell and Bispecific Therapy for Lymphoma — Part 3 of Our 6-Part ASH 2024 Friday Satellite Symposia Series

Myelofibrosis — Part 4 of Our 6-Part ASH 2024 Friday Satellite Symposia Series

Metastatic Breast Cancer — San Antonio 2024 symposium series proceedings Part 3

Chronic Myeloid Leukemia — Part 1 of Our 6-Part ASH 2024 Friday Satellite Symposia Series

Acute Myeloid Leukemia — Part 5 of Our 6-Part ASH 2024 Friday Satellite Symposia Series

The Role of Endocrine-Based Therapy in the Management of Breast Cancer — San Antonio 2024 symposium series proceedings Part 2

HER2-Low and HER2-Ultralow Breast Cancer — San Antonio 2024 symposium series proceedings Part 1

Multiple Myeloma — Part 6 of Our 6-Part ASH 2024 Friday Satellite Symposia Series

Chronic Lymphocytic Leukemia — Part 2 of Our 6-Part ASH 2024 Friday Satellite Symposia Series

Cases from the Community: Integrating New Research Findings into Current Practice — Colorectal and Gastroesophageal Cancers

Cases from the Community: Integrating New Research Findings into Current Practice — Hepatobiliary Cancers

Cases from the Community: Integrating New Research Findings into Current Practice — Gynecologic Cancers

Cases from the Community: Integrating New Research Findings into Current Practice — Myelofibrosis

Cases from the Community: Integrating New Research Findings into Current Practice — Leukemia and Myelodysplastic Syndromes

Cases from the Community: Integrating New Research Findings into Current Practice — Lung Cancer

5-Minute Journal Club Issue 2 with Dr Seth Wander: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer

Meet The Professor: Current and Future Use of Nontargeted Therapy for Metastatic Non-Small Cell Lung Cancer — A 2024 World Conference on Lung Cancer Review

Exploring the Current Management Paradigm for Patients with Metastatic Triple-Negative Breast Cancer 

Practical Perspectives: Investigators Discuss the Current Management of Paroxysmal Nocturnal Hemoglobinuria

Data + Perspectives: Clinical Investigators Explore the Application of Recent Datasets in Current Oncology Care  — Multiple Myeloma

5-Minute Journal Club Issue 1 with Dr Seth Wander: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer

The Implications of Recent Datasets for the Current and Future Management of Lung Cancer — A Review of Information from ESMO Congress 2024 and Other Conferences

Meet The Professor: Optimizing the Management of Chronic Lymphocytic Leukemia — Part 2 of a 3-Part Series

Optimizing the Management of Tenosynovial Giant Cell Tumor

Data + Perspectives: Clinical Investigators Explore the Application of Recent Datasets in Current Oncology Care  — Prostate Cancer

Data + Perspectives: Clinical Investigators Explore the Application of Recent Datasets in Current Oncology Care  — Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia

Optimizing Therapy for Patients with Hormone Receptor-Positive Metastatic Breast Cancer Harboring PI3K/AKT/PTEN Pathway Abnormalities

Data + Perspectives: Clinical Investigators Explore the Application of Recent Datasets in Current Oncology Care  — Lung Cancer

Data + Perspectives: Clinical Investigators Explore the Application of Recent Datasets in Current Oncology Care — Breast Cancer

What Clinicians Want to Know About the Current and Future Role of EZH1/2 Inhibitors in the Care of Patients with Lymphoma

Special Edition — Key Presentations on Lung Cancer from Recent Major Conferences

The Implications of Recent Datasets for the Current and Future Management of Gastrointestinal Cancers — An ESMO Congress 2024 Review

Improving Outcomes with First-Line Endocrine-Based Therapy for Patients with HR-Positive, HER2-Negative Metastatic Breast Cancer

Practical Perspectives: Optimizing the Role of BTK Inhibitors in the Management of Mantle Cell Lymphoma

Potential Role of PROTAC ER Degraders in Therapy for HR-Positive Metastatic Breast Cancer

Practical Perspectives: Current Management of Chronic Myeloid Leukemia

The Implications of Recent Datasets for the Current and Future Management of Small Cell Lung Cancer — A 2024 World Conference on Lung Cancer Review

Practical Perspectives: Optimizing Diagnosis and Treatment for Patients with Desmoid Tumors

Peripheral T-Cell Lymphoma

The Implications of Recent Datasets for the Current and Future Use of Nontargeted Therapy for Metastatic Non-Small Cell Lung Cancer

Meet The Professor: Optimizing the Management of Chronic Lymphocytic Leukemia — Part 1 of a 3-Part Series

The Implications of Recent Datasets for the Current and Future Management of Non-Small Cell Lung Cancer with Actionable Targets Beyond EGFR

The Implications of Recent Datasets for the Current and Future Management of Non-Small Cell Lung Cancer with EGFR Mutations

Optimizing the Management of Metastatic BRCA-Negative, Triple-Negative Breast Cancer

Striving for Consensus: Optimizing the Current and Future Management of Biliary Tract Cancers

Inside the Issue: Optimizing the Diagnosis and Treatment of Neuroendocrine Tumors

Inside the Issue: Integrating HER2-Targeted Strategies into the Management of Gastrointestinal Cancers

Optimizing the Management of Dedifferentiated Liposarcoma